MiRXES: Southeast Asia's Biotech Unicorn
Dr Zhou Lihan, Co-founder and CEO, MiRXES Holding Co Ltd
03-Dec-25 08:00
Embed Podcast
You can share this podcast by copying this HTML to your clipboard and pasting into your blog or web page.
Close
MiRXES is a Singaporean biotech company that’s listed on the Hong Kong stock exchange. Today Elaine Boey will be sitting down with co-founder and CEO, Dr. Zhou Lihan to talk about the technology that the company employs, challenges as Southeast Asia’s biotech unicorn, when it might turn profitable, and whether you should be a shareholder.
Image Credit: Shutterstock.com
Produced by: Deena Khadeja
Presented by: Elaine Boey
This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.
Categories: wellness, managing disease, medical advances
Tags: Southeast Asia’s biotech unicorn, MiRXES, singaporean company, biotechnology, hong kong stock exchange,
